Medigus to Begin Clinical Study in China for CFDA Regulatory Clearance
Feb 08, 2016 07:00 am UTC| Business
Medigus receives first purchase order from Golden Grand-Medical Instruments Ltd. to advance commercial agreement Study results to be used for CFDA regulatory clearance process OMER, Israel, Feb. 08, 2016 -- Medigus...
DBV Technologies to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
Feb 08, 2016 06:58 am UTC| Business
MONTROUGE, France, Feb. 8, 2016 -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced that Charles Ruban, Chief...
VALNEVA Signs New R&D Collaboration with GlaxoSmithKline for the EB66(r) Cell Line
Feb 08, 2016 06:08 am UTC| Business
Valneva to supply process development services for EB66-based Influenza vaccines Advanced Development program sponsored by the US Department of Health and Human Services Valneva to receive research fees under the...
INNATE PHARMA : Start of Phase I clinical trial of monalizumab in combination with durvalumab
Feb 08, 2016 06:06 am UTC| Business
Multicenter, open-label, dose-escalation and cohort-expansion Phase I study of durvalumab in combination with monalizumab in patients with solid tumors; Trial performed by AstraZeneca/MedImmune in the United States and...
Feb 08, 2016 06:00 am UTC| Business
MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2016 -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular...
Verizon certifies Gemalto's first Cat. 1 LTE M2M Solution for IoT
Feb 08, 2016 06:00 am UTC| Business
AMSTERDAM, The Netherlands, Feb. 8, 2016 -- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, announces its leading edge Cinterion Cat. 1 LTE M2M module is Verizon certified to connect to the...
Ferroglobe PLC Announces Dividend
Feb 08, 2016 04:01 am UTC| Business
LONDON, Feb. 08, 2016 -- Ferroglobe PLC (Nasdaq:GSM) announced that its Board of Directors on February 3, 2016 declared a special dividend of $0.08 per share payable on March 14, 2016 to shareholders of record at the...